Millions of women during higher-than-usual risk of breast cancer have a new choice for preventing a disease. Pfizer Inc.’s Aromasin cut a risk of building breast cancer by some-more than half, yet a side effects that have tempered unrestrained for other impediment drugs, a vital investigate found. It was a initial exam in healthy women [...]
↧